result break org growth
price reiter outperform
manag exce guidanc street expect top bottom
view mdt result anoth import step toward return
compani manag long-run goal sustain annual organ growth
ep growth growth benefit strength number
key growth driver includ tavr us spine us
remain track launch addit key product addit see acceler
growth new product carri follow fiscal year posit
meet exceed long-run growth target well reiter
outperform rate rais target price
org growth cse management guidanc pipelin
track drive organ growth acceler sequenti
take pressur put track meet exceed guid
expect org growth better line guidanc
acceler growth driven part low-risk tavr micra av leadless
pacer reveal linq insert monitor robot spine surgeri mazorx
ep guidanc rais org sale growth guid maintain management
rais sale growth outlook cvg mitg rtg togeth compris
mdt total sale despit in-lin result diabet total sale management lower
full-year outlook low-single-digit growth believ
degre anticip investor ep guid rais
chang model maintain org growth estim rais
ep estim line mgmt revis outlook
valuat target price prev base ebitda multipl
unchang ntm ebitda estim bil one year forward prev bil
multipl roughli in-lin mdt current trade multipl risk product
delay failur progress long-term goal growth margin potenti new
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
mariu zoican univers toronto rotman school manag litig regulatori qualiti issu
mariu zoican univers toronto rotman school manag novemb
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
medtron plc global manufactur provid medic devic
equip area cardiac rhythm manag vascular
intervent structur valvular diseas spinal disord
neuromodul surgic equip diabet
one-year valuat scenario base
ev/ebitda ebitda
scenario base emerg segment deliv
growth high-growth segment grow growth grow
one-year valuat grey scenario base
ev/ebitda grey ebitda
grey scenario base emerg segment deliv
growth high-growth segment grow growth grow
 close
mariu zoican univers toronto rotman school manag
addit detail takeaway
cvg bil mil y/i cc
organ vs cse
 heart failur sale bil mil declin organ
arrhythmia manag grew lsd driven pace af micra grew
drive msd pacer growth icd ldd vs msd previous af ldd
driven continu uptak arctic front cryoballoon diagnost grew lsd driven
continu uptak reveal linq heart failur ldd mid-teen crt-p growth
off-set continu crt-d replac lvad headwind lvad declin
ww y/i
coronari structur heart sale mil mil increas
organ perform led ww tavr growth mid-teen last quarter
 driven continu strong uptak evolut expans
low risk patient coronari growth declin lsd mid-teen strength guid cathet
off-set declin de
aortic peripher venou sale mil mil decreas
organ perform led growth taa driven uptak valiant
navion thorac stent graft system thorac endovascular repair venou grew lsd vs hsd
last quarter led on-going adopt venas closur system dcb busi
declin ww compani gain share dcb
manag expect cvg grow prior guidanc
mitg bil mil y/i cc
surgic innov sale bil mil increas organ
advanc surgic msd driven convers surgic procedur open
minim invas advanc energi msd driven contribut new launch
advanc stapl msd driven tri-stapl endo stapl specialti reload
eea circular stapler tri-stapl technolog colorect procedur gener
surgic grew msd result back-ord recoveri result impact
respiratori gastrointestin renal sale mil mil increas
organ perform led hsd growth patient monitor gi solut
respiratori grew msd renal flat growth off-set
manag expect mitg grow prior guidanc
rtg bil mil y/i cc
brain therapi sale mil mil increas organ
neurovascular high-teen includ ldd growth hemorrhag growth
ischem stroke therapi product hemorrhag growth led growth flow
divers strong adopt solitair stent retriev riptid aspir
system drove ischem growth neurosurgeri ldd result continu strong
demand stealthstat navig system o-arm imag system mazor
mariu zoican univers toronto rotman school manag novemb
pain therapi sale mil mil increas organ pain
reflect slowdown market management call posit
trial growth intervent sale ldd back strong kyphon bkp
osteocool rf ablat system sale
spine sale mil mil increas organ spine combin
enabl
neurosurgeri grew lsd spine growth driven robot
implant pull-through well recent product launch includ infin oct system
solid growth prestig lp cervic disc system
specialti therapi sale mil mil increas organ
perform driven hsd ent growth driven capit equip sale
stealthstat ent surgic navig system intraop nim nerv monitor system
power ent instrument pelvic health lsd compani submit
pma fda interstim micro interstim surescan mri lead
manag expect rtg grow vs prior guidanc
diabet mil mil y/i cc
ou sale account half total sale offset competit
pressur sale declin hsd due on-going competit pressur cgm growth
driven ww strength integr stand alon cgm system integr cgm
growth led increas cgm penetr well new patient acquisit stand-alon
cgm driven guardian connect smart cgm system grew insulin
growth driven on-going ou minim system launch off-set
competit pressur compani report high-teen growth western europ
expect launch franc addit insulin pump high-
teen em compani expect present pivot data februari attd
manag expect diabet grow lsd previous
 oper margin bp
sale net cog in-lin lower sg lower tax partial off-set
lower non-op incom higher deliv beat rel estim
street gross margin bp y/i bp
estim oper margin bp y/i
manag maintain sale growth guidanc fx expect repres
headwind unchang previou expect compani increas
ep guidanc manag continu expect
bp oper margin expans compani guid ep
mariu zoican univers toronto rotman school manag novemb
estimate bpother bpop bpnon-op bpnet chg y/i mariu zoican univers toronto rotman school manag novemb
estimate var salesy/i chg cc chg org chg salesy/i chg cc chg org chg gastro mariu zoican univers toronto rotman school manag novemb
chang model
made minor adjust sale estim leav organ growth
estim unchang weve rais ep estim in-lin
guidanc made minor adjust sale ep estim
figur chang model
 peripher gastrointestin mariu zoican univers toronto rotman school manag novemb
compani mention price
matt miksic vik chopra certifi respect compani secur individu analyz view express
report accur reflect person view subject compani secur part
compens directli indirectli relat specif recommend view express report
